Frank Torti
Executive Chairperson
Other
Other
Chairman
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | $725,000 | $123,300,566 |
Executive changes
Earnings-call appearances
-
Immunovant, Inc. Q1 FY2022 Earnings Call2021-08-09
Immunovant, Inc. (IMVT)